Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chae-Min Ryu

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Clinical Medicine|September 9, 2020
Therapeutic Efficacy of Human Embryonic Stem Cell-Derived Multipotent Stem/Stromal Cells in Diabetic Detrusor Underactivity: A Preclinical StudyJung Hyun Shin, Chae-Min Ryu, Hyein Ju, et al.
Scientific Reports|November 10, 2019
Induction of detrusor underactivity by extensive vascular endothelial damages of iliac arteries in a rat model and its pathophysiology in the genetic levelsMyong Kim, Hwan Yeul Yu, Hyein Ju, et al.
Experimental & Molecular Medicine|February 10, 2023
Activating transcription factor-2 supports the antioxidant capacity and ability of human mesenchymal stem cells to prevent asthmatic airway inflammationHyein Ju, HongDuck Yun, YongHwan Kim, et al.
Stem Cell Reviews and Reports|June 30, 2021
A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder IschemiaHwan Yeul Yu, Jung Hyun Shin, HongDuck Yun, et al.
Stem Cells Translational Medicine|September 7, 2022
Safety of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells for Treating Interstitial Cystitis: A Phase I StudyJung Hyun Shin, Chae-Min Ryu, Hwan Yeul Yu, et al.
Clinical and Translational Medicine|July 29, 2021
Small-sized mesenchymal stem cells with high glutathione dynamics show improved therapeutic potency in graft-versus-host diseaseJisun Lim, Jinbeom Heo, Hwan Yeul Yu, et al.
Experimental & Molecular Medicine|June 21, 2022
The CDK1/TFCP2L1/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancerJinbeom Heo, Jinyoung Lee, Yun Ji Nam, et al.
Theranostics|December 18, 2018
Longitudinal intravital imaging of transplanted mesenchymal stem cells elucidates their functional integration and therapeutic potency in an animal model of interstitial cystitis/bladder pain syndromeChae-Min Ryu, Hwan Yeul Yu, Hye-Yeon Lee, et al.
Biomaterials|December 3, 2021
Intravital imaging and single cell transcriptomic analysis for engraftment of mesenchymal stem cells in an animal model of interstitial cystitis/bladder pain syndromeHwan Yeul Yu, Seungun Lee, Hyein Ju, et al.
EMBO Molecular Medicine|November 12, 2019
Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesisJinbeom Heo, Byeong-Joo Noh, Seungun Lee, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Clinical Medicine|September 9, 2020
Therapeutic Efficacy of Human Embryonic Stem Cell-Derived Multipotent Stem/Stromal Cells in Diabetic Detrusor Underactivity: A Preclinical StudyJung Hyun Shin, Chae-Min Ryu, Hyein Ju, et al.
Scientific Reports|November 10, 2019
Induction of detrusor underactivity by extensive vascular endothelial damages of iliac arteries in a rat model and its pathophysiology in the genetic levelsMyong Kim, Hwan Yeul Yu, Hyein Ju, et al.
Experimental & Molecular Medicine|February 10, 2023
Activating transcription factor-2 supports the antioxidant capacity and ability of human mesenchymal stem cells to prevent asthmatic airway inflammationHyein Ju, HongDuck Yun, YongHwan Kim, et al.
Stem Cell Reviews and Reports|June 30, 2021
A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder IschemiaHwan Yeul Yu, Jung Hyun Shin, HongDuck Yun, et al.
Stem Cells Translational Medicine|September 7, 2022
Safety of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells for Treating Interstitial Cystitis: A Phase I StudyJung Hyun Shin, Chae-Min Ryu, Hwan Yeul Yu, et al.
Clinical and Translational Medicine|July 29, 2021
Small-sized mesenchymal stem cells with high glutathione dynamics show improved therapeutic potency in graft-versus-host diseaseJisun Lim, Jinbeom Heo, Hwan Yeul Yu, et al.
Experimental & Molecular Medicine|June 21, 2022
The CDK1/TFCP2L1/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancerJinbeom Heo, Jinyoung Lee, Yun Ji Nam, et al.
Theranostics|December 18, 2018
Longitudinal intravital imaging of transplanted mesenchymal stem cells elucidates their functional integration and therapeutic potency in an animal model of interstitial cystitis/bladder pain syndromeChae-Min Ryu, Hwan Yeul Yu, Hye-Yeon Lee, et al.
Biomaterials|December 3, 2021
Intravital imaging and single cell transcriptomic analysis for engraftment of mesenchymal stem cells in an animal model of interstitial cystitis/bladder pain syndromeHwan Yeul Yu, Seungun Lee, Hyein Ju, et al.
EMBO Molecular Medicine|November 12, 2019
Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesisJinbeom Heo, Byeong-Joo Noh, Seungun Lee, et al.
Pageof 3